Get the Stockscreener App
8.25
2.83%
-0.2401
After Hours:
8.25
Pharming Group N V Adr stock is traded at $8.25, with a volume of 774.
It is down -2.83% in the last 24 hours and up +7.28% over the past month.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
See More
Previous Close:
$8.4901
Open:
$8.25
24h Volume:
774
Relative Volume:
0.13
Market Cap:
$559.64M
Revenue:
$277.56M
Net Income/Loss:
$-13.33M
P/E Ratio:
-31.73
EPS:
-0.26
Net Cash Flow:
$-6.54M
1W Performance:
+7.73%
1M Performance:
+7.28%
6M Performance:
-23.89%
1Y Performance:
-27.63%
1-Day Range:
$8.25
$8.25
1-Week Range:
$7.60
$8.65
52-Week Range:
$6.65
$13.20
Pharming Group N V Adr Stock (PHAR) Company Profile
Pharming Group N V Adr Stock (PHAR) Latest News
Earnings call: Pharming Group reports robust growth and pipeline expansion - Investing.com India
Earnings call: Pharming Group reports robust growth and pipeline expansion - Investing.com
Pharming Group stock hits 52-week low at $6.9 amid challenges - Investing.com
Shoals Technologies, Affirm Holdings, Apple And Other Big Stocks Moving Higher On Tuesday By Benzinga - Investing.com UK
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ... - Investing.com UK
J.M. Smucker Posts Upbeat Earnings, Joins Toro Company, United Natural Foods, Semtech And Other Big Stocks ... - Investing.com UK
Bath & Body Works, Designer Brands And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionBa - Benzinga
Bath & Body Works, Designer Brands And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session By Benzinga - Investing.com UK
Bath & Body Works, Designer Brands And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Magenta (MGTA) Down on Pipeline Update for Leukemia Drug - Yahoo Canada Shine On
Earnings call: Pharming Group reports strong Q1 growth, eyes global expansion - Investing.com South Africa
Earnings call: Pharming Group reports strong Q1 growth, eyes global expansion - Investing.com
Earnings call: Pharming Group reports strong Q1 growth, eyes global expansion By Investing.com - Investing.com UK
Pharming Group reports first quarter 2024 financial results and provides business update - Investing.com India
Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains? - Zacks Investment Research
Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains? - Yahoo Finance
Landsbankinn hf.: Results of the 2024 AGM of Landsbankinn | GlobeNewswire by notified - NTB Kommunikasjon
Heineken® Celebrates Historic Irish Pubs With Virtual Museums Launch | GlobeNewswire by notified - NTB Kommunikasjon
PHAR Stock Quote Price and Forecast - CNN
PHARMING GROUP NV Trade Ideas — TRADEGATE:PHGN — TradingView - TradingView
Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up - Nasdaq
How Investors Can Grab Better Returns for Retail and Wholesale Using the Zacks ESP Screener - Zacks Investment Research
Wolters Kluwer to Acquire eOriginal | GlobeNewswire by notified - NTB Kommunikasjon
PHARM Stock Price and Chart — EURONEXT:PHARM - TradingView
Pharming Group N V Adr Stock (PHAR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):